Akkermansia muciniphila: Could It Be a New Alternative to Prevention from Obesity and Diabetes?

Yıl 2019, Sayı: 16, 533 - 543, 31.08.2019

Lütfiye Ekici , Havva Polat

https://doi.org/10.31590/ejosat.563713

Cited By: 3

Öz

Akkermansia muciniphila is one of the members of the gastrointestinal microbiota which has been recently isolated from the human fecal sample and attracted attention. The results obtained from scientific studies suggest that Akkermansia muciniphila may be an alternative solution to today's important health problems such as diabetes and obesity. This effect of Akkermansia result from the reduction of metabolic endotoxemia by modulating the mucus thickness and intestinal barrier integrity positively by the ability to degrade the mucin. Akkermansia is also effective by increasing the secretion of GLP-1 which stimulates insulin secretion. Nutritional habits of people, alcohol consumption, metmorphine and antibiotic treatments are among the factors that directly affect the density of Akkermansia in the intestine. It was determined that the polyphenol, probiotic and prebiotic contents of the foods included in the diets of individuals had effects on the number of Akkermansia. The aim of this review is to evaluate the factors affecting the importance and activity of Akkermansia muciniphila in intestinal flora. In addition, it is aimed to compile the literature data on mechanism of the action of Akkermansia muciniphila on obesity and diabetes.

Anahtar Kelimeler

Gastrointestinal microbiota, Akkermansia muciniphila, Diabetes mellitus, Obesite

Akkermansia muciniphila: Obezite ve Diyabetten Korunmada Yeni Bir Alternatif Olabilir mi?

Öz

Akkermansia muciniphila, insan fekal örneğinden yakın tarihte izole edilen ve
dikkatleri üzerine çeken gastrointestinal mikrobiyota üyelerinden biridir.
Bilimsel çalışmalardan elde edilen sonuçlar, Akkermansia muciniphila’ nın diyabet ve obezite gibi günümüzün
önemli sağlık sorunlarına karşı alternatif bir çözüm olabileceğini
düşündürmektedir. Akkermansia’ nın bu
etkisi, müsini degrade edebilme yeteneği sayesinde mukus kalınlığını ve
bağırsak bariyer bütünlüğünü pozitif şekilde modüle ederek metabolik
endotoksemiyi azaltmasından kaynaklanmaktadır. Akkermansia insülin salgılanmasını uyaran GLP-1 hormonunu
sekresyonunu arttırarak da etkili olmaktadır. İnsanların beslenme
alışkanlıkları, alkol tüketimi, metmorfin ve antibiyotik tedavileri
bağırsaktaki Akkermansia yoğunluğunu
birebir etkileyen faktörler arasındadır. Bireylerin diyetlerinde yer alan
gıdaların polifenol, probiyotik ve prebiyotik içeriklerinin de Akkermansia sayısı üzerine etkilerinin
olduğu belirlenmiştir. Bu derlemenin amacı, Akkermansia
muciniphila’ nın bağırsak florasındaki önemi ve aktivitesi üzerine etkili
faktörlerin değerlendirilmesidir. Ayrıca,
Akkermansia muciniphila’ nın obezite ve diyabet üzerine etki mekanizması
konusundaki literatür verilerinin derlenmesi hedeflenmiştir.

Anahtar Kelimeler

Gastrointestinal mikrobiyota, Akkermansia muciniphila, Diyabetes mellitus

Kaynakça

• Alard, J., Lehrter, V., Rhimi, M., Mangin, I., Peucelle, V., Abraham, A. L., & Grangette, C. (2016). Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota. Environmental Microbiology, 18(5), 1484–1497. https://doi.org/10.1111/1462-2920.13181
• Altunkaynak, B. Z.,& Özbek, E. (2006). Obezite: Nedenleri ve tedavi seçenekleri. Van Tıp Dergisi, 13(4), 138–142.
• Altuntaş, Y.,& Batman, A., (2017). Mikrobiyota ve metabolik sendrom. Türk Kardiyoloji Derneği Arşivi 45(3), 286-296. https://dx.doi.org/10.5543/tkda.2016.72461American Diabetes Association. (2014). Diagnosis and classification of autoimmune diabetes mellitus. Diabetes Care, 37(1), 81–90. https://doi.org/10.2337/dc14-S081
• Anhê, F.F., Roy, D., Pilon, G., Dudonné, S., Matamoros, S., Varin, T.V., Garofalo, C., Moine, Q., Desjardins, Y., Levy, E.,& Marette, A.(2015). A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut, 64(6), 872–883. https://doi.org/10.1136/gutjnl-2014-307142
• Axling, U.,Olsson, C., Xu, J., Fernandez, C., Larsson, S., Ström,K., Ahrné, S., Holm, C., Molin, G.,&Berger, K. (2012). Green tea powder and Lactobacillus plantarum affect gut microbiota, lipid metabolism and inflammation in high-fat fed C57BL/6J mice. Nutrition and Metabolism, 9(1), 1–18. https://doi.org/10.1186/1743-7075-9-105
• Baggio, L. L.,& Drucker, D. J. (2007). Biology of incretins: GLP-1 and GIP. Gastroenterology, 132(6), 2131–2157. https://doi.org/10.1053/j.gastro.2007.03.054
• Baldwin, J.,Collins, B., Wolf, P. G., Martinez, K., Shen, W., Chuang, C. C., Zhong, W., Cooney, P., Cockrell, C., Chang, E., Gaskins H. R., McIntosh, M. K. (2017). Table grape consumption reduces adiposity and markers of hepatic lipogenesis and alters gut microbiota in butter fat-fed mice. The Journal of Nutritional Biochemistry, 27, 123–135. https://doi.org/10.1016/j.jnutbio.2015.08.027
• Bayly, G. R., (2014). Lipids and disorders of lipoprotein metabolism. William J. Marshall, Marta Lapsley, Andrew P. Day& Ruth M. Ayling (Ed.), In Clinical Biochemistry: Metabolic and Clinical Aspects (s. 702-736) içinde. Churchill Livingstone
• Belzer, C.,& De Vos, W. M. (2012). Microbes inside from diversity to function: The case of Akkermansia. ISME Journal,6(8),1449–1458. https://doi.org/10.1038/ismej.2012.6
• Blandino, G.,Inturri, R., Lazzara, F., DiRosa, M., & Malaguarnera, L. (2016). Impact of gut microbiota on diabetes mellitus. Diabetes and Metabolism, 42(5), 303–315. https://doi.org/10.1016/j.diabet.2016.04.004
• Brahe, L. K., Le Chatelier, E., Prifti, E., Pons, N., Kennedy, S., Hansen, T., Pedersen, O., Astrup, A., Ehrlich, S.D., &Larsen, L. H.(2015). Specific gut microbiota features and metabolic markers in postmenopausal women with obesity. Nutrition and Diabetes, 5(6), e159-7.
• Candela, M.,Biagi, E., Turroni, S., Maccaferri, S., Figini, P., &Brigidi, P. (2015). Dynamic efficiency of the human intestinal microbiota. Critical Reviews in Microbiology, 41(2), 165–171. https://doi.org/10.3109/1040841X.2013.813900
• Cani, P. D.,Knauf, C., Iglesias, M. A., Drucker, D. J., Delzenne, N. M., & Burcelin, R. (2006). Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes, 55(5), 1484–1490. https://doi.org/10.2337/db05-1360
• Ceyhan, N.,& Alıç, H.(2012). Bağırsak mikroflorası ve probiyotikler. Türk Bilimsel Derlemeler Dergisi, 5(1): 107-113.
• Clarke, S.F., Murphy, E.F., O'Sullivan, O., Lucey, A.J., Humphreys, M., Hogan, A., Hayes, P., O'Reilly, M., Jeffery, I.B., Wood-Martin, R., Kerins, D.M., Quigley, E., Ross, R.P., O'Toole, P.W., Molloy, M.G., Falvey, E., Shanahan, F.,&Cotter, P.D.(2014). Exercise and associated dietary extremes impact on gut microbial diversity. Gut, 63(12), 1913–1920. https://doi.org/10.1136/gutjnl-2013-306541
• Chan, Y. K.,Estaki, M., & Gibson, D. L. (2013). Clinical consequences of diet-induced dysbiosis. Annals of Nutrition and Metabolism, 63(2), 28–40. https://doi.org/10.1159/000354902
• Choque Delgado, G. T., & Tamashiro, W. M. da S. C. (2018). Role of prebiotics in regulation of microbiota and prevention of obesity. Food Research International, 113(April), 183–188. https://doi.org/10.1016/j.foodres.2018.07.013
• Collado, M. C., Derrien, M., Isolauri, E., De Vos, W. M., & Salminen, S. (2007). Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Applied and Environmental Microbiology, 73(23), 7767–7770. https://doi.org/10.1128/AEM.01477-07
• Collado, M. C.,Isolauri, E., Laitinen, K., & Salminen, S. (2008). Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. The American Journal of Clinical Nutrition, 88, 894–899. https://doi.org/10.1093/ajcn/88.4.894
• Collado, M. C.,Isolauri, E., Laitinen, K., &Salminen, S. (2010). Effect of mother’ s weight on infant’ s microbiota acquisition, composition, and activity during early in fancy: a prospective. The American Journal of Clinical Nutrition, 92, 1023-1030. https://doi.org/10.3945/ajcn.2010.29877
• Conlon, M. A.,&Bird, A. R. (2015). The impact of diet and lifestyle on gut microbiota and human health. Nutrients, 7(1), 17–44. https://doi.org/10.3390/nu7010017
• Çolak, R. (2012). Tip 2 diabetes mellitus tedavisinde inkretinler. Deneysel ve Klinik Tıp Dergisi 29: 30-38. https://doi.org/10.5835/jecm.omu.29.s1.007
• Daglia, M. (2012). Polyphenols as antimicrobial agents. Current Opinion in Biotechnology, 23(2), 174–181. https://doi.org/10.1016/j.copbio.2011.08.007
• Dao, M.C.,Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E.O., Kayser, B.D., Levenez, F., Chilloux, J., Hoyles, L., Dumas, M.E., Rizkalla, S.W., Doré, J., Cani, P.D.,&Clément, K. (2015). Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: Relationship with gut microbiomerichness and ecology. Gut, 65(3), 426–436. https://doi.org/10.1136/gutjnl-2014-308778
• Derrien, M.,Vaughan, E. E., Plugge, C. M., & de Vos, W. M. (2004). Akkermansia municiphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. International Journal of Systematic and Evolutionary Microbiology, 54(5), 1469–1476. https://doi.org/10.1099/ijs.0.02873-0
• Derrien, M.,Collado, M.C., Ben-Amor, K., Salminen, S., de Vos, W.M. (2008). The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Applied and Environmental Microbiology, 74(5), 1646–1648. https://doi.org/10.1128/aem.01226-07
• Derrien, M.,Passel, M. W. J. Van, Bovenkamp, J. H. B. Van De, Schipper, R. G., Vos, W. M. De, & Dekker, J. (2010). Structural mucin of intestinal mucus in human and mouse, Gut Microbes1(4), 254–268.
• Derrien, M., Van Baarlen, P., Hooiveld, G., Norin, E., Müller, M.,& de Vos, W. M. (2011). Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila. Frontiers in Microbiology, 2, 1–14. https://doi.org/10.3389/fmicb.2011.00166
• Dubourg, G.,Lagier, J. C., Armougom, F., Robert, C., Audoly, G., Papazian, L., & Raoult, D. (2013). High-level colonisation of the human gut by Verrucomicrobia following broad-spectrum antibiotic treatment. International Journal of Antimicrobial Agents, 41(2), 149–155. https://doi.org/10.1016/j.ijantimicag.2012.10.012
• Escobar, J. S., Klotz, B., Valdes, B. E.,& Agudelo, G. M. (2015). The gut microbiota of Colombians differs from that of Americans, Europeans and Asians. BMC Microbiology, 14(1), 1–14. https://doi.org/10.1186/s12866-014-0311-6
• Everard, A.,Lazarevic, V., Derrien, M., Girard, M., Muccioli, G. G., Neyrinck, A. M., Possemiers, S., Holle, A.V., François, P., de Vos, W.M., Delzenne, N.M., Schrenzel, Jacques.,& Cani, P. D.(2011). Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes, 60(11), 2775–2786. https://doi.org/10.2337/db11-0227
• Everard, A.,& Cani, P. D. (2013). Diabetes, obesity and gut microbiota. Best Practice and Research: Clinical Gastroenterology, 27(1), 73–83. https://doi.org/10.1016/j.bpg.2013.03.007
• Everard, A.,Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart C., Bindels, L.B., Guiot, Y., Derrien, M., Muccioli, G.G., Delzenne, N.M., de Vos, W.M., & Cani, P.D.(2013). Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the National Academy of Sciences, 110(22), 9066–9071. https://doi.org/10.1073/pnas.1219451110
• Fabersani, E.,Russo, M., Marquez, A., Abeijón-Mukdsi, C., Medina, R.,& Gauffin-Cano, P.(2018). Modulation of intestinal microbiota and immuno metabolic parameters by caloric restriction and lactic acid bacteria. Food Research International. https://doi.org/10.1016/j.foodres.2018.06.014
• Federico, A., Dallio, M., Di Sarno, R., Giorgio, V.,&Miele, L. (2017). Gut microbiota, obesity and metabolic disorders. Minerva Gastroenterologica E Dietologica, 63(4), 337-344.https://doi.org/10.23736/S1121-421X.17.02376-5
• García-Peña, C.,Álvarez-Cisneros, T., Quiroz-Baez, R., &Friedland, R. P. (2017). Microbiota and Aging. A Review and Commentary. Archives of MedicalResearch, 48(8), 681–689. https://doi.org/10.1016/j.arcmed.2017.11.005
• Gibson, P. R.,&Shepherd, S. J. (2005). Personal view: Food for thought - Western lifestyle and susceptibility to Crohn’s disease. The FODMAP hypothesis. Alimentary Pharmacology and Therapeutics, 21(12), 1399–1409. https://doi.org/10.1111/j.1365-2036.2005.02506.x
• Goossens, D.,Jonkers, D., Stobberingh, E., van den Bogaard, A., Russel, M.,& Stockbrügger, R., 2003. Probiotics in gastroenterology: Indications and future perspectives. Scandinavian Journal of Gastroenterology, 23, 15-23.
• Goto, T.,Edén, S., Nordenstam, G., Sundh, V., Svanborg-Edén, C.,& Mattsby, B.I.(1994). Endotoxin levels in sera of elderly individuals. Clinical and Diagnostic Laboratory Immunology, 1(6), 684-688.
• Guarner, F.,& Malagelada, J.R. (2003). Gut flora in health and disease. Lancet, 361(9356), 512-519. https://doi.org/10.1016/S0140-6736(03)12489-0
• Guarner, F.,Sanders, M.E., Eliakim, R., Fedorak, R., Gangl, A., Garisch, J., Kaufmann, P., Karakan, T., Khan A.G., Kim, N., Andrés De Paula, J., Ramakrishna, B., Shanahan, F., Szajewska, Hania., Thomson, A., & Le Mair, A. (2017). Probiotics and prebiotics. World Gastroenterology Organisation Global Guidelines.
• Halmos, E. P.,Christophersen, C. T., Bird, A. R., Shepherd, S. J., Gibson, P. R., &Muir, J. G. (2015). Dietsthatdiffer in their FODMAP contental terthe colonic luminal micro environment. Gut, 64(1), 93–100. https://doi.org/10.1136/gutjnl-2014-307264
• Halmos, E. P., Christophersen, C. T., Bird, A. R., Shepherd, S. J., Muir, J. G., & Gibson, P. R. (2016). Consistent prebiotic effect on gut microbiota with altered FODMAP intake in patients with Crohnʼs disease: A randomised, controlled cross-over trial of well-defined diets. Clinical and Translational Gastroenterology, 7(4), e164. https://doi.org/10.1038/ctg.2016.22
• Han, J. L.,& Lin, H. L. (2014). Intestinal microbiota and type 2 diabetes: From mechanism insight stotherapeutic perspective. World Journal of Gastroenterology, 20(47), 17737–17745. https://doi.org/10.3748/wjg.v20.i47.17737
• Hansen, C. H.,Krych, L., Nielsen, D.S., Vogensen, F.K., Hansen, L.H., Sørensen, S.J., Buschard, K., & Hansen, A.K. (2012). Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia, 55(8), 2285–2294. https://doi.org/10.1007/s00125-012-2564-7
• Haque, T. R.,& Barritt, A. S. (2016). Intestinal microbiota in liver disease. Best Practice and Research: Clinical Gastroenterology, 30(1), 133–142. https://doi.org/10.1016/j.bpg.2016.02.004
• Hooper, L. V.,& Gordon, J. I. (2001). Commensal host-bacterial relationships in the gut. Science, 292(5519), 1115-1118.
• Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 444(712), 840. https://doi.org/10.1038/nature05482
• Kanengoni, A. T., Chimonyo, M., Tasara, T., Cormican, P., Chapwanya, A., Ndimba, B. K., & Dzama, K. (2015). A comparison of faecal microbial populations of South African Windsnyer-type indigenous pigs (SAWIPs) and Large White × Landrace (LW × LR) crosses fed diets containing ensiled maize cobs. FEMS Microbiology Letters, 362(13), fnv100. https://doi.org/10.1093/femsle/fnv100
• Karlsson, C. L. J., Önnerfält, J., Xu, J., Molin, G., Ahrné, S., & Thorngren-Jerneck, K. (2012). The microbiota of the gut in preschool children with normal and excessive body weight. Obesity, 20(11), 2257–2261. https://doi.org/10.1038/oby.2012.110
• Kemperman, R. A., Gross, G., Mondot, S., Possemiers, S., Marzorati, M., Van de Wiele, T., Doré, J., & Vaughan, E. E. (2013). Impact of polyphenols from black tea and red wine/grape juice on a gut model microbiome. Food Research International, 53(2), 659–669. https://doi.org/10.1016/j.foodres.2013.01.034
• Koçak, T., Şanlıer, N. (2017). Mikrobesin öğeleri ve mikrobiyota etkileşimi. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, 6(4), 290-302.
• Kong, C., Gao, R., Yan, X., Huang, L., & Qin, H. (2018). Probiotics improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet. Nutrition, 60, 175-184. https://doi.org/10.1016/j.nut.2018.10.002
• Koenig, J. E., Spor, A., Scalfone, N., Fricker, A. D., Stombaugh, J., Knight, R., … Ley, R. E. (2011). Succession of microbial consortia in the developing infant gut microbiome. Proceedings of the National Academy of Sciences, 108(1), 4578–4585. https://doi.org/10.1073/pnas.1000081107
• Koloğlu, S. (1996). Diabetes Mellitus. Endokrinoloji, Temel ve Klinik. Koloğlu S. (ed), Medical Network & Nobel, Birinci Baskı, (s.368-385) içinde. Ankara.
• Kuzu, F. (2017). Bağırsak mikrobiyotasının obezite, insülin direnci ve diyabetteki rolü. Journal of Biotechnology and Strategic Health Research, 1, 68-80.
• Lee, H., & Ko, G. (2014). Effect of metformin on metabolic improvement and gut microbiota. Applied and Environmental Microbiology, 80(19), 5935–5943. https://doi.org/10.1128/aem.01357-14
• Lee, Y. K., & Mazmanian, S. K. (2010). Has the microbiota played a critical role in the evolution of the adaptive immune system? Science, 330(6012), 1768–1773. https://doi.org/10.1126/science.1195568
• Li, J., Lin, S., Vanhoutte, P.M., Woo, C.W.,& Xu, A. (2016). Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in Apoe-/- Mice. Circulation 133(24), 2434-2446. https://doi.org/10.1161/circulationaha.115.019645
• Li, Z., Henning, S. M., Lee, R.-P., Lu, Q.-Y., Summanen, P. H., Thames, G., Corbett, K., Downes, J., Tseng, C.H., Finegold, S. M., & Heber, D. (2015). Pomegranate extract induces ellagitannin metabolite formation and changes stool microbiota in healthy volunteers. Food & Function, 6(8), 2487–2495. https://doi.org/10.1039/c5fo00669d
• Liu, X., Fan, H., Ding, X., Hong, Z., Nei, Y., Liu, Z., Li, G., & Guo, H. (2014). Analysis of the gut microbiota by high-throughput sequencing of the V5–Vv6 regions of the 16s rRna gene in donkey. Current Microbiology, 68(5), 657–662. https://doi.org/10.1007/s00284-014-0528-5
• Mackowiak, P.A. (1982). The normal microbial flora. New England Journal of Medicine, 307(2),83-93. https://doi.org/10.1056/NEJM198207083070203
• Manichanh, C., Reeder, J., Gibert, P., Varela, E., Llopis, M., Antolin, M., Guigo, R., Knight, R.,& Guarner, F. (2010). Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. Genome Research, 20(10), 1411–1419. https://doi.org/10.1101/gr.107987.110
• McLaughlin, T., Abbasi, F., Carantoni, M., Schaaf, P.,& Reaven, G. (1999). Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women. The Journal of Clinical Endocrinology & Metabolism 84(2): 578-581. https://doi.org/10.1210/jcem.84.2.5441
• McLaughlin, T. L., & Reaven, G. M. (2003). Beyond type 2 diabetes: The need for a clinically useful way to identify insulin resistance. The American Journal of Medicine, 114(6), 501–502. https://doi.org/.1016/s0002-9343(03)00122-0
• Napolitano, A., Miller, S., Nicholls, A. W., Baker, D., Van Horn, S., Thomas, E., Rajpal, D., Spivak, A., Brown, J.R., Nunez, D. J. (2014). Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus. PLoS ONE, 9(7), 1–14. https://doi.org/10.1371/journal.pone.0100778
• Nauck, M., Frid, A., Hermansen, K., Shah, N. S., Tankova, T., Mitha, I. H., Matthews, D. R.,& for the LEAD-2 Study Group (2009). Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination the LEAD ( Liraglutide Effect and Action in Diabetes )- LEAD 2 study. Diabetes Care, 32(1), 84-90. https://doi.org/10.2337/dc08-1355.Clinical
• Neyrinck, A. M., Etxeberria, U., Taminiau, B., Daube, G., Van Hul, M., Everard, A., Cani, P.D., Bindels L. B.,& Delzenne, N. M. (2017). Rhubarb extract prevents hepatic inflammation induced by acute alcohol intake, an effect related to the modulation of the gut microbiota. Molecular Nutrition and Food Research, 61(1), 1–12. https://doi.org/10.1002/mnfr.201500899
• Onkamo, P., Väänänen, S., Karvonen, M., & Tuomilehto, J. (1999). Worldwide increase in incidence of type I diabetes - The analysis of the data on published incidence trends. Diabetologia, 42(12), 1395–1403. https://doi.org/10.1007/s001250051309
• Org, E., Parks, B.W., Joo, J.W., Emert, B., Schwartzman, W., Kang, E.Y., Mehrabian, M., Pan, C., Knight, R., Gunsalus, R., Drake, T.A., Eskin, E., Lusis A.J. (2015). Genetic and environmental control of host-gut microbiota interactions. Genome Research, 25(10), 1558–1569. https://doi.org/10.1101/gr.194118.115
• Ottman, N., Geerlings, S. Y., Aalvink, S., Vos, W. M. De, & Belzer, C. (2017). The discovery of Akkermansia muciniphila has opened new avenues for the use of this. Best Practice & Research Clinical Gastroenterology. https://doi.org/10.1016/j.bpg.2017.10.001
• Overton, H.A., Babbs, A.J., Doel, S.M., Fyfe, M.C., Gardner, L.S., Griffin, G., Jackson, H.C., Procter, M.J., Rasamison, C.M., Tang-Christensen, M., Widdowson, P.S., Williams, G.M.,& Reynet, C.(2006). Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metabolism, 3(3), 167–175. https://doi.org/10.1016/j.cmet.2006.02.004
• Overton, H.A., Fyfe, M.C., Reynet, C. (2008) . GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity. British Journal of Pharmacology 153 (1), 76-81. https://doi.org/10.1038/sj.bjp.0707529
• Özden, A. (2006). Sağlıklı Yaşam İçin Yararlı Dost Bakteriler. Türk Gastroentoloji Vakfı Yayınları, Ankara.
• Özyurt, V. H. & Ötles, S.(2014). Properties of probiotics and encapsulated probiotics in food. Acta Scientiarum Polonorum, Technologia Alimentaria, 13(4), 413-424. https://doi.org/10.17306/J.AFS.2014.4.8
• Parkar, S. G., Stevenson, D. E., & Skinner, M. A. (2008). The potential influence of fruit polyphenols on colonic microflora and human gut health. International Journal of Food Microbiology, 124(3), 295–298. https://doi.org/10.1016/j.ijfoodmicro.2008.03.017
• Pérez-Cobas, A. E., Gosalbes, M. J., Friedrichs, A., Knecht, H., Artacho, A., Eismann, K., Otto, W., Rojo, D., Bargiela, R., von Bergen, M., Neulinger, S.C., Däumer, C., Heinsen, F.A., Latorre, A., Barbas, C., Seifert, J., dos Santos, V.M., Ott, S.J., Ferrer, M.,& Moya, A.. (2014). Gut microbiota disturbance during antibiotic therapy: A multi-omic approach. Gut Microbes, 5(1), 64–70. https://doi.org/10.4161/gmic.27128
• Reid, G., Younes, J. A., Van Der Mei, H. C., Gloor, G. B., Knight, R., & Busscher, H. J. (2011). Microbiota restoration: Natural and supplemented recovery of human microbial communities. Nature Reviews Microbiology, 9(1), 27–38. https://doi.org/10.1038/nrmicro2473
• Reid, D. T., Eller, L. K., Nettleton, J. E., & Reimer, R. A. (2016). Postnatal prebiotic fibre intake mitigates some detrimental metabolic outcomes of early overnutrition in rats. European Journal of Nutrition, 55(8), 2399–2409. https://doi.org/10.1007/s00394-015-1047-2
• Roberfroid, M., Gibson, G., Hoyles, L., McCartney, A., Rastall, R., Rowland, I., Wolvers, D., Watzl, B., Szajewska, H., Stahl, B., Guarner, F., Respondek, F., Whelan, K., Coxam, V., Davicco, M.J., Léotoing, L., Wittrant, Y., Delzenne, N.M., Cani, P.D., & Ne, A. (2010). Prebiotic effects: Metabolic and health benefits. British Journal of Nutrition, 104(2), 1–63. https://doi.org/10.1038/159869b0
• Rodes, L., Khan, A., Paul, A., Coussa, C. M., Marinescu, D., Tomaro D. C., Shao,W., Kahouli, I.,& Prakash, S. (2013). Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in vitro study using a human colonic microbiota model. Journal of Microbiology and Biotechnology, 23(4), 518–526.
• Roopchand, D. E., Carmody, R. N., Kuhn, P., Moskal, K., Rojas-Silva, P., Turnbaugh, P. J., & Raskin, I. (2015). Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high fat diet-induced metabolic syndrome. Diabetes, 64(8), 2847–2858.
• Santacruz, A., Collado, M., García-Valdés, L., Segura, M., Martín-Lagos, J., Anjos, T., Martí-Romero, M., Lopez, R.M., Florido, J., Campoy, C., Sanz, Y. (2010). Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. British Journal of Nutrition, 104(1), 83–92. https://doi.org/10.1017/S0007114510000176
• Schley, P. D., & Field C.J. (2003). The immune-enhancing effects of dietary fibres and prebiotics. British Journal of Nutrition, 87(6), 221–230. https://doi.org/10.1079/bjnbjn/2002541
• Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010). Microbiota and SCFA in lean and overweight healthy subjects. Obesity, 18(1), 190–195. https://doi.org/10.1038/oby.2009.167
• Shin, N. R., Lee, J. C., Lee, H. Y., Kim, M. S., Whon, T. W., Lee, M. S., & Bae, J. W. (2014). An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut, 63(5), 727–735. https://doi.org/10.1136/gutjnl-2012-303839
• Tailford, L. E., Crost, E. H., Kavanaugh, D., & Juge, N. (2015). Mucin glycan foraging in the human gut microbiome. Frontiers in Genetics, 6(81). https://doi.org/10.3389/fgene.2015.00081
• Tannock, G. W., Munro, K., Harmsen, H. J. M., Welling, G. W.,& Smart, J. (2000). Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Applied and Environmental Microbiology, 66(6), 2578–2588. https://doi.org/10.1128/aem.66.6.2578-2588.2000
• Tekin, T., Çiçek, B.,& Konyalıgil, N. (2018). İntestinal mikrobiyota ve obezite ilişkisi. Sağlık Bilimleri Dergisi, 27, 95–99.
• Yetkin, İ., Satış, H., & Satış, N. K. (2017). Bağırsak mikrobiyotasının insülin direnci, diabetes mellitus ve obezite ile ilişkisi. Türkiye Diyabet ve Obezite Dergisi, 1: 1-8.
• Yılmaz, K., & Altındiş, M. (2017). Sindirim sistemi mikrobiyotasi ve fekal transplantasyon. Nobel Medicus, 13(1), 9–15.
• Zhang, X., Shen, D., Fang, Z., Jie, Z., Qiu, X., Zhang, C., … Ji, L. (2013). Human gut microbiota changes reveal the progression of glucose intolerance. PLoS ONE, 8(8), e71108. https://doi.org/10.1371/journal.pone.0071108
• Zhou, Z. Y., Ren, L. W., Zhan, P., Yang, H. Y., Chai, D. D.,& Yu, Z. W. (2016). Metformin exerts glucose-lowering action in high-fat fed mice via attenuating endotoxemia and enhancing insulin signaling. Acta Pharmacologica Sinica, 37(8), 1063–1075. https://doi.org/10.1038/aps.2016.21
• Zhou, K. (2017). Strategies to promote abundance of Akkermansia muciniphila, an emerging probiotics in the gut, evidence from dietary intervention studies. Journal of Functional Foods, 33, 194–201. https://doi.org/10.1016/j.jff.2017.03.045